NVision
PrivateLast Round
Series B
May 13, 2026
Est. Valuation
$250M
Total Funding Raised
$194.3M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NVision is a quantum technology company that develops quantum-based systems for healthcare, including quantum-enhanced MRI for metabolic imaging and quantum computing for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Drug Discovery, Quantum Computing, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NVision Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NVision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2026 | ||||
| Series B | May 13, 2026 | ||||
| Grant | Mar 16, 2026 | ||||
| Series B | May 13, 2024 | ||||
| Series A | Jun 22, 2023 |
NVision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| European Commission | Seed |
| Entrée Capital | Series B, Series A |
| Kapitalbeteiligungsgesellschaft der Kreissparkasse Esslingen-Nürtingen mbH | Series A |
| European Investment Bank Group | Series B |
| Matterwave Ventures | Series B |
| CDP Venture Capital SGR | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$55M round led by Abbott Laboratories.
- May 13, 2026
$55M round led by Abbott Laboratories
NVision Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NVision's valuation, stock price, and market status.